Innovation Center for Airway and Inflammation Research (I-CAIR) Research
at the STRF

“Our findings indicate that the environment of the lung triggers toxin production. We have been able to develop state-of-the-art systems to observe infection and toxin production using live cell and whole animal imaging.

We believe CARDS TX is a most important virulence factor of airway diseases, and these key studies will lead to innovative treatments of serious acute and chronic pulmonary pathologies.”

 

Joel B. Baseman, Ph.D.
Professor and Chair
Microbiology & Immunology, UT Health Science Center at San Antonio

Startling statistics:

• According to the American Lung Association, lung disease is the third-leading killer in America, responsible for 1 in 6 deaths. Lung disease and other breathing problems constitute one of the leading causes of death in children younger than 1 year old. Today, more than 35 million Americans are living with chronic lung disease such as asthma, and chronic obstructive pulmonary disease (COPD) otherwise known as emphysema and chronic bronchitis.

Read about some of our diabetes research news:

• Respiratory disease research receives NIH grant
  
  
• Health Science Center researchers put the freeze on a respiratory toxin after 50 years